Gene therapy, particularly the CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-associated protein 9) system, holds promise in treating FOP by specifically targeting the ACVR1 gene mutation. The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.